Mesh Bio
Singapore · Founded 2024 · $5.3M raised
- Founded
- 2024
- Business Model
- B2B
- Website
- meshbio.com
- Total Funding
- $5.3M
- Last Round
- $3.5M Series AFeb 2024
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.
About
Southeast Asian healthtech startup using predictive analytics and digital twin models to help clinicians diagnose and manage chronic disease.
Summary
Mesh Bio is an Analytics company based in Singapore, founded in 2024. It has raised $5.3M in total across 2 rounds, most recently a $3.5M Series A round in Feb 2024. Investors include East Ventures, Elev8 VC and Mitsui & Co., Ltd..
Funding History
Feb 2024
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Neuralink develops investigational implantable brain-computer interfaces that help people with pa...
Databricks provides a unified data and AI platform that helps enterprises build and run applicati...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Palantir Technologies builds data integration and analytics platforms (Gotham and Foundry) for go...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/mesh-bio"><img src="https://indexed.vc/api/badge/company/mesh-bio" alt="Mesh Bio on Indexed.vc" width="260" height="76" /></a>